| Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
| Veids | Citi |
| Valoda | EN |
| Statuss | Publicēts |
| Versija | |
| Datums | 2011-01-12 09:24:22 |
| Versijas komentārs | |
| Teksts |
Olaine, January 12, 2011
“Olainfarm” will have invested about 4 million lats
in a new product
As „Olainfarm” over the period of more than four years
will have invested about 4 million lats in development of a new
product. Development of the said product was started in
2006.
The company plans to use the resources of EU structural
funds under the activity „Introduction of new products and
technologies” managed by Latvian Investment and Development
Agency.
AS „Olainfarm“ is one of the largest companies in
Baltic countries with nearly 40 years of experience in production
of medicines and chemical and pharmaceutical products. The key
principle of company's operations is to produce reliable and
effective top quality products for Latvia and the rest of the
world. Currently products of “Olainfarm” are being exported to
more than 30 countries worldwide, including the Baltics, Russia,
other CIS, Europe, North America, Asia, and
Australia.
Information prepared by:
Salvis Lapins
Member of the Board
A/s „Olainfarm”
Tel: +371 6 7013 717
Fax: +371 6 7013 777
E-mail: slapinsh@olainfarm.lv |
| Pielikumi |
|